Literature DB >> 15882548

Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study.

Sekar Kathiresan1, Martin G Larson, Emelia J Benjamin, Diane Corey, Joanne M Murabito, Caroline S Fox, Peter W F Wilson, Nader Rifai, James B Meigs, Gesa Ricken, Richard P Lifton, Daniel Levy, Ramachandran S Vasan.   

Abstract

BACKGROUND: We investigated the environmental and genetic sources of interindividual variability in serum aldosterone level in a large, community-based sample.
METHODS: We examined the relation of serum aldosterone to vascular risk factors, urine sodium, and candidate single nucleotide polymorphisms in 2891 Framingham Offspring Study participants (53.2% women, mean age 59 years) using multivariable linear regression. Multivariable logistic regression was used to identify predictors of high (top quartile) and low (lowest quartile) serum aldosterone values. We estimated heritability of serum aldosterone via variance-component methods and evaluated linkage via a 10-cM-density genome scan.
RESULTS: Clinical variables related to higher serum aldosterone level included female sex, diuretic treatment, and a higher total/high density lipoprotein cholesterol ratio. A high urinary sodium excretion, postmenopausal status (without hormone replacement therapy), increased pulse pressure, and prevalent cardiovascular disease were related to lower serum aldosterone values. Urinary sodium was the strongest correlate of serum aldosterone (R2= 10%). Serum aldosterone levels did not differ by genotype in the aldosterone synthase (CYP11B2c.1-344C>T) and the mineralocorticoid receptor (NR3C2c.754A>G) genes. The estimated heritability of serum aldosterone was 0.10. No chromosomal region attained a log-of-the-odds score >1 in multipoint linkage analysis.
CONCLUSIONS: We observed a complex relation between serum aldosterone and vascular risk factors. The genetic contribution to serum aldosterone level was modest.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882548     DOI: 10.1016/j.amjhyper.2004.12.005

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  30 in total

Review 1.  The role of aldosterone in the metabolic syndrome.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

2.  Different polymorphisms of the mineralocorticoid receptor gene are associated with either glucocorticoid or mineralocorticoid levels in hypertension.

Authors:  Bei Sun; Bindu Chamarthi; Jonathan S Williams; Alexander W Krug; Jessica Lasky-Su; Benjamin A Raby; Paul N Hopkins; Xavier Jeunemaitre; Claudio Ferri; Gordon H Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-06-20       Impact factor: 5.958

3.  Histone demethylase LSD1 deficiency and biological sex: impact on blood pressure and aldosterone production.

Authors:  Yuefei Huang; Pei Yee Ting; Tham M Yao; Tsuyoshi Homma; Danielle Brooks; Isis Katayama Rangel; Gail K Adler; Jose R Romero; Jonathan S Williams; Luminita H Pojoga; Gordon H Williams
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

Review 4.  Aldosterone and cardiovascular risk.

Authors:  Bruno Vogt; Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

5.  Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways.

Authors:  Sarama Saha; Juergen Graessler; Peter E H Schwarz; Claudia Goettsch; Stefan R Bornstein; Steffi Kopprasch
Journal:  Mol Cell Biochem       Date:  2012-03-01       Impact factor: 3.396

6.  Analysis of baseline parameters in the HALT polycystic kidney disease trials.

Authors:  Vicente E Torres; Arlene B Chapman; Ronald D Perrone; K Ty Bae; Kaleab Z Abebe; James E Bost; Dana C Miskulin; Theodore I Steinman; William E Braun; Franz T Winklhofer; Marie C Hogan; Frederic R Oskoui; Cass Kelleher; Amirali Masoumi; James Glockner; Neil J Halin; Diego R Martin; Erick Remer; Nayana Patel; Ivan Pedrosa; Louis H Wetzel; Paul A Thompson; J Philip Miller; Catherine M Meyers; Robert W Schrier
Journal:  Kidney Int       Date:  2011-12-28       Impact factor: 10.612

Review 7.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

Review 8.  Aldosterone and the risk of hypertension.

Authors:  Vanessa Xanthakis; Ramachandran S Vasan
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

9.  Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males.

Authors:  Alexander W Krug; Lissy Stelzner; Ajaykumar D Rao; Andrew H Lichtman; Gordon H Williams; Gail K Adler
Journal:  Metabolism       Date:  2012-09-21       Impact factor: 8.694

10.  Baseline Serum Aldosterone-to-Renin Ratio is Associated with the Add-on Effect of Thiazide Diuretics in Non-Diabetic Essential Hypertensives.

Authors:  Chin-Chou Huang; Hsin-Bang Leu; Po-Hsun Huang; Tao-Cheng Wu; Shing-Jong Lin; Jaw-Wen Chen
Journal:  Acta Cardiol Sin       Date:  2013-01       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.